Stock Events
Stock Events
Search...
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (ALNY) Q2 2019 Earnings
ALNY
1
May
Confirmed
Q3 2018
Q4 2018
Q1 2019
Q2 2019
-2.43
-2.19
-1.96
-1.72
Details
Expected EPS
-2.09
Actual EPS
-1.73
Surprise EPS
0.36
Surprise Percent
+17.22%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.73 per share for Q2 2019.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist